GI & Endoscopy

A capital investment firm is attempting to buy 1.5 million shares of AbbVie common stock at $88.05 per share in a mini-tender offer. 

Here are the five most-read Becker's ASC Review articles for gastroenterologists the week of June 8-12:

Fight Colorectal Cancer is holding a virtual symposium June 11 to discuss the rising incidence rate of early-onset colorectal cancer. 

The World Gastroenterology Organization and the Biocodex Microbiota Institute entered into a partnership to raise awareness of gut microbiota.

Oral surgeons took the biggest financial hit from COVID-19, followed by gastroenterologists, according to Fair Health's 2020 "Healthcare Professionals and the Impact of COVID-19" report, a comparative study of revenue and utilization.

Here are eight updates from gastroenterology companies and practices from the past week: 

AbbVie and MBC BioLabs named Bacchus Therapeutics and PTM Therapeutics recipients of the 2020 AbbVie Golden Ticket.

Steroid-sparing therapies can help children and young adults prevent complications of Crohn's disease, according to a study published in JAMA Network Open.

A handful of deals have transpired in the gastroenterology space since the beginning of May.

Boston Scientific (NYSE: BSX) announced that the Centers for Medicare & Medicaid Services (CMS) has approved its application for a transitional pass-through (TPT) payment category to describe single-use endoscopes, including the EXALT™ Model D Single-Use Duodenoscope, under the Medicare hospital…